Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Perspectives for tailored chemoprevention and treatment of colorectal cancer in Lynch syndrome.

Heijink DM, de Vries EG, Koornstra JJ, Hospers GA, Hofstra RM, van Vugt MA, de Jong S, Kleibeuker JH.

Crit Rev Oncol Hematol. 2011 Nov;80(2):264-77. doi: 10.1016/j.critrevonc.2010.11.009. Epub 2010 Dec 14. Review.

PMID:
21159521
2.

Prophylactic surgery in Lynch syndrome.

Celentano V, Luglio G, Antonelli G, Tarquini R, Bucci L.

Tech Coloproctol. 2011 Jun;15(2):129-34. doi: 10.1007/s10151-010-0666-0. Epub 2011 Feb 2. Review.

PMID:
21287222
3.

Colorectal cancer due to deficiency in DNA mismatch repair function: a review.

Bellizzi AM, Frankel WL.

Adv Anat Pathol. 2009 Nov;16(6):405-17. doi: 10.1097/PAP.0b013e3181bb6bdc. Review.

PMID:
19851131
4.

Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer).

Vasen HF.

Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:113-26. doi: 10.1111/j.1365-2036.2007.03479.x. Review.

5.
6.

Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics.

Imai K, Yamamoto H.

Carcinogenesis. 2008 Apr;29(4):673-80. Epub 2007 Oct 17. Review.

PMID:
17942460
7.
8.

Microsatellite instability in the management of colorectal cancer.

Pino MS, Chung DC.

Expert Rev Gastroenterol Hepatol. 2011 Jun;5(3):385-99. doi: 10.1586/egh.11.25. Review.

PMID:
21651356
9.

Hereditary colorectal cancer syndromes.

Strate LL, Syngal S.

Cancer Causes Control. 2005 Apr;16(3):201-13. Review.

PMID:
15947872
10.
11.

Mismatch repair genes in Lynch syndrome: a review.

Silva FC, Valentin MD, Ferreira Fde O, Carraro DM, Rossi BM.

Sao Paulo Med J. 2009 Jan;127(1):46-51. Review.

12.

DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome.

Poulogiannis G, Frayling IM, Arends MJ.

Histopathology. 2010 Jan;56(2):167-79. doi: 10.1111/j.1365-2559.2009.03392.x. Review.

PMID:
20102395
13.

Pathology of the hereditary colorectal carcinoma.

Gatalica Z, Torlakovic E.

Fam Cancer. 2008;7(1):15-26. Epub 2007 Jun 13. Review.

PMID:
17564815
14.

Chemoprevention in hereditary colorectal cancer syndromes.

Hawk E, Lubet R, Limburg P.

Cancer. 1999 Dec 1;86(11 Suppl):2551-63. Review.

PMID:
10630181
15.

Lynch syndrome and related familial colorectal cancers.

Abdel-Rahman WM, Peltomäki P.

Crit Rev Oncog. 2008;14(1):1-22; discussion 23-31. Review.

PMID:
19105568
16.

Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications.

Lynch HT, Boland CR, Gong G, Shaw TG, Lynch PM, Fodde R, Lynch JF, de la Chapelle A.

Eur J Hum Genet. 2006 Apr;14(4):390-402. Review.

17.

[Essential to discover hereditary colorectal and endometrial cancer. Mutations in "HNPCC individuals" can cause several different tumors].

Nilbert M, Grönberg H, Lindblom A.

Lakartidningen. 2002 Aug 22;99(34):3296-300. Review. Swedish.

PMID:
12362848
18.

[Hereditary colorectal cancer].

Möslein G.

Chirurg. 2008 Nov;79(11):1038-46. doi: 10.1007/s00104-008-1557-z. Review. German.

PMID:
18853126
19.

Colorectal surveillance in Lynch syndrome families.

de Vos tot Nederveen Cappel WH, Järvinen HJ, Lynch PM, Engel C, Mecklin JP, Vasen HF.

Fam Cancer. 2013 Jun;12(2):261-5. doi: 10.1007/s10689-013-9631-1. Review.

PMID:
23525799
20.

Hereditary colorectal cancer: clinical consequences of predictive molecular testing.

Hahn M, Saeger HD, Schackert HK.

Int J Colorectal Dis. 1999 Nov;14(4-5):184-93. Review.

PMID:
10647626

Supplemental Content

Support Center